HTA Database - Search Results

Sort by Relevance

Search Results [15895 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2021	Penn Medicine Center for Evidence-based Practice (CEP)	Palliative care screening tools
2021	Penn Medicine Center for Evidence-based Practice (CEP)	Procalcitonin for antimicrobial discontinuation in hospitalized adult patients
2021	Penn Medicine Center for Evidence-based Practice (CEP)	Prone positioning of patients on extracorporeal membrane oxygenation (ECMO)
2021	Institute for Clinical Effectiveness and Health Policy (IECS)	[Ketoanalogs in association with high protein diet in chronic kidney failure]
2021	Institute for Clinical Effectiveness and Health Policy (IECS)	[Precice® motorized intramedullary nail system for limb-length discrepancy]
2021	Institute for Clinical Effectiveness and Health Policy (IECS)	[Direct-acting oral anticoagulants for postoperative thrombosis prophylaxis]
2021	Institute for Clinical Effectiveness and Health Policy (IECS)	[Genetic testing for lynch syndrome in colorectal cancer and family members]
2021	NIHR Public Health Research (PHR) programme	School-based interventions to prevent anxiety, depression and conduct disorder in children and young people: a systematic review and network meta-analysis
2021	Penn Medicine Center for Evidence-based Practice (CEP)	Opioid pain assessment
2021	Penn Medicine Center for Evidence-based Practice (CEP)	Effectiveness of intra-operative antimicrobial irrigation to prevent surgical site infection in clean surgeries
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: long-term left ventricular assist devices, real-world evolving portrait of use and outcomes in Québec from 2010 to 2017]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: alcohol withdrawal and relapse prevention]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: relevance of using mpMRI for the diagnostic investigation of prostate cancer - mpMRI and prostate cancer diagnosis]
2021	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Fear of childbirth, depression and anxiety during pregnancy]
2021	Norwegian Institute of Public Health (NIPH)	[Evaluation of PD-L1 assays in urothelial carcinoma: a rapid HTA]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: use of single-photon emission computed tomography with [ 123I]ioflupane (DaTscan) in the diagnostic process for parkinsonian syndromes]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: relevance of neonatal pulse oximetry screening for critical congenital heart disease]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: mammographic density and breast cancer screening]
2021	Swiss Federal Office of Public Health (FOPH)	Long-term physiotherapy in patients after stroke, with multiple sclerosis, or with Parkinson’s disease
2021	Austrian Institute for Health Technology Assessment (AIHTA)	[Sponsoring of patient initiatives in Austria. Update of the systematic analyses 2014 to 2018]
2021	Austrian Institute for Health Technology Assessment (AIHTA)	[Epidemiology of long COVID: a preliminary report. German short version of the original KCE report]
2021	Austrian Institute for Health Technology Assessment (AIHTA)	Implantation of bulking agents for faecal incontinence. Update 2021: systematic review
2021	Austrian Institute for Health Technology Assessment (AIHTA)	Percutaneous left ventricular assist devices: micro-axial flow pumps: systematic review
2021	Austrian Institute for Health Technology Assessment (AIHTA)	Liposuction for surgical therapy of lipoedema: systematic review
2021	Austrian Institute for Health Technology Assessment (AIHTA)	Triphasic biomaterial for augmentation of the osteoporotic femoral neck: systematic review
2021	Austrian Institute for Health Technology Assessment (AIHTA)	Endoscopic plication therapy in patients with gastroesophageal reflux disease (GERD): systematic review
2021	Austrian Institute for Health Technology Assessment (AIHTA)	Allogenic bone screw Shark Screw® in patients with hallux valgus or scaphoid fractures/pseudarthroses: systematic review
2021	Austrian Institute for Health Technology Assessment (AIHTA)	(Good) practice organisational models using real-world evidence for public funding of high priced therapies
2021	Austrian Institute for Health Technology Assessment (AIHTA)	[Non-interventional studies (NIS) in Austria, 2nd update of systematic analyses 2016 & 2017]
2021	Norwegian Institute of Public Health (NIPH)	[Autologous stem cell transplantation for multiple sclerosis : rapid scoping review]
2021	Scottish Health Technologies Group (SHTG)	Elective surgery using mesh to repair primary or incisional hernias in adults
2021	Scottish Health Technologies Group (SHTG)	A Unique Device Identifier (UDI) system for recording, identifying and recalling medical devices
2021	NIHR Health Technology Assessment programme	A prognostic model, including quantitative fetal fibronectin, to predict preterm labour: the QUIDS meta-analysis and prospective cohort study
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: evolving profile of the use and clinical outcomes of transcatheter aortic valve implantation (TAVI) and surgical aortic valve implantation (SAVR) in Québec, a real-world evaluation from 2013 to 2019]
2021	Health Technology Wales (HTW)	Extracorporeal shockwave therapy for the treatment of musculoskeletal conditions
2021	Austrian Institute for Health Technology Assessment (AIHTA)	HSR in Oncology: patients with non-small cell lung cancer treated with anti-PD-1/PD-L1 therapy in real-world practice. A pilot project in cooperation with Tirol Kliniken GmbH & KAGes
2021	Belgian Health Care Knowledge Centre (KCE)	Benefits and costs of innovative oncology drugs in Belgium (2004-2017)
2021	Health Information and Quality Authority (HIQA)	Interventions in an ambulatory setting to prevent progression to severe disease in patients with COVID-19
2021	Health Information and Quality Authority (HIQA)	Extended interval screening by the Diabetic RetinaScreen Programme in Ireland
2021	Health Information and Quality Authority (HIQA)	Measures to support people in self-isolation or restriction of movements and the evidence of the effectiveness of such measures
2021	Health Information and Quality Authority (HIQA)	Potential impact of different serial testing scenarios using rapid antigen detection tests (RADTs) to detect SARS-CoV-2 in meat processing plant workers
2021	Health Information and Quality Authority (HIQA)	Analysis of factors associated with outbreaks of SARS-CoV-2 in nursing homes in Ireland
2021	Health Information and Quality Authority (HIQA)	Potential impact of different testing scenarios and durations of mandatory home quarantine for people travelling to Ireland from non-designated states
2021	Health Information and Quality Authority (HIQA)	Public health measures to limit the transmission of SARS-CoV-2 at mass gatherings
2021	Health Information and Quality Authority (HIQA)	Duration of immunity (protection from reinfection) following SARS-CoV-2 infection
2021	Health Information and Quality Authority (HIQA)	COVID-19 - interventions and health related factors that prevent infection or minimise progression to severe disease
2021	Health Information and Quality Authority (HIQA)	Review of processes in use to inform the expansion of newborn bloodspot screening programmes
2021	Health Information and Quality Authority (HIQA)	Economic burden of antimicrobial resistance: an analysis of additional costs associated with resistant infections
2021	Health Information and Quality Authority (HIQA)	Health technology assessment of birth cohort testing for hepatitis C
2021	Health Information and Quality Authority (HIQA)	Identification of demand models for estimating the quantities of personal protective equipment (PPE) required for optimal patient care in the context of COVID-19
2021	Health Information and Quality Authority (HIQA)	Rapid antigen testing for screening or surveillance of asymptomatic individuals to limit transmission of SARS-CoV-2
2021	Health Information and Quality Authority (HIQA)	Reduction of the minimum age for the application of mask wearing requirements and recommendations – updated advice
2021	NIHR Health Technology Assessment programme	Reducing bias in trials from reactions to measurement: the MERIT study including developmental work and expert workshop
2021	Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS)	[Training programming for healthcare professionals: How to support patients with chronic diseases to self-manage their health]
2021	Ontario Health	Stance-control knee–ankle–foot orthoses for people with knee instability: a health technology assessment
2021	Austrian Institute for Health Technology Assessment (AIHTA)	Stool DNA testing for colorectal cancer (CRC) screening
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: hospital at home, an alternative to conventional hospitalization]
2021	NIHR Health Technology Assessment programme	Non-invasive imaging software to assess the functional significance of coronary stenoses: a systematic review and economic evaluation
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: needs analysis grid for families followed by Integrated Perinatal and Early Childhood Services (SIPPE)]
2021	Penn Medicine Center for Evidence-based Practice (CEP)	Fall risk assessment in oncology patients
2021	Penn Medicine Center for Evidence-based Practice (CEP)	Effects of masks on the health of schoolchildren
2021	NIHR Health Technology Assessment programme	Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis
2021	Belgian Health Care Knowledge Centre (KCE)	Long COVID: Pathophysiology – epidemiology and patient needs
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: creation and characterization of a Québec lung cancer patient cohort using clinical administrative data]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: consent process and disposition options for embryos preserved following in vitro fertilization]
2021	Austrian Institute for Health Technology Assessment (AIHTA)	[Nivolumab in malignant melanoma: contrasting the evidence from pivotal trials with real world evidence (RWE)]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: submission of surgical specimens to the anatomic pathology laboratory - relevance and indications - orthopedic surgery and neurosurgery]
2021	Health Technology Wales (HTW)	Handheld single lead electrocardiogram devices to detect atrial fibrillation in older adults and those with intermittent episodes
2021	Health Technology Wales (HTW)	Point-of-care ultrasound to diagnose gallstone disease
2021	Health Technology Wales (HTW)	Natriuretic peptides to rule-in and rule-out a diagnosis of acute heart failure in adults in the emergency department setting
2021	Penn Medicine Center for Evidence-based Practice (CEP)	Ambulatory antibiotic prophylaxis for skin procedures
2021	Health Technology Wales (HTW)	Strategies for Relatives (START) intervention to improve the mental health of carers of people with dementia
2021	Belgian Health Care Knowledge Centre (KCE)	Remote monitoring of patients with cardiovascular implantable electronic devices: a health technology assessment (update of the KCE Report 136)
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: Rebinyn (nonacog beta pegol) – Type B hemophilia (re-evaluation)]
2021	Austrian Institute for Health Technology Assessment (AIHTA)	Long COVID care pathways: a systematic review
2021	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Percutaneous repair systems for tricuspid valve insufficiency by annuloplasty]
2021	Health Information and Quality Authority (HIQA)	Duration of immunity (protection from reinfection) following SARS-CoV-2 infection
2021	NIHR Health Technology Assessment programme	Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model
2021	Austrian Institute for Health Technology Assessment (AIHTA)	[Process and evaluation of digital health applications in the context of "symptom-checkers"]
2021	Austrian Institute for Health Technology Assessment (AIHTA)	National strategies and programmes for preventing and managing non-communicable diseases in selected countries
2021	Penn Medicine Center for Evidence-based Practice (CEP)	Tracheostomy or endotracheal tubes and subglottic suctioning
2021	Health Information and Quality Authority (HIQA)	Review of international ethics frameworks used in policy-making in the context of screening
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: efficacy and safety of onasemnogene abeparvovec, nusinersen and risdiplam for the treatment of spinal muscular atrophy]
2021	NIHR Health Technology Assessment programme	Improving continence in children and young people with neurodisability: a systematic review and survey
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: assessment of the relevance of newborn screening for spinal muscular atrophy]
2021	Swiss Federal Office of Public Health (FOPH)	Effectiveness and safety of vitamin B12 tests
2021	Andalusian Health Technology Assessment Area (AETSA)	[Laser interstitial thermal therapy for patients with refractory epilepsy: safety and effectiveness. A systematic review]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: care pathways leading to the diagnostic assessment of neurodevelopmental disorders in children 0-7 years old]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: relevance of and indications for submitting surgical specimens to the anatomic pathology laboratory: obstetrics/gynecology and urology]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: relevance of and indications for submitting surgical specimens to the anatomic pathology laboratory: general surgery, plastic surgery and dermatology]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: optimal use of immunoglobulins in infectious diseases]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: portrait of the use of home care and support services by people at the end-stages of life in Québec, 2013-2018]
2021	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Amikacin (Mycobacterium avium complex pulmonary infections)]
2021	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Atidarsagen autotemcel (metachromatic leukodystrophy with biallelic mutation in the ARSA gene)]
2021	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Autologous anti-CD19-transduced CD3+ cells (mantle cell lymphoma, pretreated patients)]
2021	The Federal Joint Committee (G-BA)	[Pharamceutical Directive/Annex XII: Avapritinib (gastrointestinal stromal tumours)]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: microbiological stool testing in adults and children with diarrhea: relevance and measures to promote judicious use]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: pertussis - diagnostic modalities and trajectory]
2021	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Bedaquiline (new therapeutic indication: pulmonary multidrug-resistant tuberculosis, 5 to 11 years)]
2021	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Belantamab mafodotin (multiple myeloma, at least 4 prior therapies, monotherapy)]